BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18055911)

  • 1. Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.
    De Luca A; Bottillo I; Dasdia MC; Morella A; Lanari V; Bernardini L; Divona L; Giustini S; Sinibaldi L; Novelli A; Torrente I; Schirinzi A; Dallapiccola B
    J Med Genet; 2007 Dec; 44(12):800-8. PubMed ID: 18055911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 single and multi-exons copy number variations in neurofibromatosis type 1.
    Imbard A; Pasmant E; Sabbagh A; Luscan A; Soares M; Goussard P; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanne-Chantelot C; Vidaud D; Wolkenstein P; ; Parfait B
    J Hum Genet; 2015 Apr; 60(4):221-4. PubMed ID: 25631097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exonic deletions in the NF1 gene in patients with neurofibromatosis type I from the lower Silesian region of Poland.
    Laczmańska I; Szczepaniak M; Jakubiak A; Stembalska A
    Adv Clin Exp Med; 2014; 23(4):517-21. PubMed ID: 25166435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.
    Wimmer K; Yao S; Claes K; Kehrer-Sawatzki H; Tinschert S; De Raedt T; Legius E; Callens T; Beiglböck H; Maertens O; Messiaen L
    Genes Chromosomes Cancer; 2006 Mar; 45(3):265-76. PubMed ID: 16283621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative outcomes of pathogenic complex somatic structural variations in the genomes of NF1 and NF2 patients.
    Hsiao MC; Piotrowski A; Poplawski AB; Callens T; Fu C; Messiaen L
    Neurogenetics; 2017 Jul; 18(3):169-174. PubMed ID: 28285357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis.
    Murugan S; Chandramohan A; Lakshmi BR
    Indian J Med Res; 2010 Sep; 132():303-11. PubMed ID: 20847377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients.
    Nemethova M; Bolcekova A; Ilencikova D; Durovcikova D; Hlinkova K; Hlavata A; Kovacs L; Kadasi L; Zatkova A
    Ann Hum Genet; 2013 Sep; 77(5):364-79. PubMed ID: 23758643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PKHD1 multiexon deletions using multiplex ligation-dependent probe amplification and quantitative polymerase chain reaction.
    Zvereff V; Yao S; Ramsey J; Mikhail FM; Vijzelaar R; Messiaen L
    Genet Test Mol Biomarkers; 2010 Aug; 14(4):505-10. PubMed ID: 20575693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].
    Li H; Ding J; Wang W; Chen Y; Lu W; Shao H; Wu BL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):318-22. PubMed ID: 19504448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly sensitive genetic protocol to detect NF1 mutations.
    Valero MC; Martín Y; Hernández-Imaz E; Marina Hernández A; Meleán G; Valero AM; Javier Rodríguez-Álvarez F; Tellería D; Hernández-Chico C
    J Mol Diagn; 2011 Mar; 13(2):113-22. PubMed ID: 21354044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele.
    Orzan F; Stroppi M; Venturin M; Valero MC; Hernández C; Riva P
    Neurogenetics; 2008 May; 9(2):95-100. PubMed ID: 18196300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
    Kayes LM; Burke W; Riccardi VM; Bennett R; Ehrlich P; Rubenstein A; Stephens K
    Am J Hum Genet; 1994 Mar; 54(3):424-36. PubMed ID: 8116612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1: Expanded variant spectrum with multiplex ligation-dependent probe amplification and genotype-phenotype correlation in 138 Turkish patients.
    Güneş N; Yeşil G; Geyik F; Kasap B; Celkan T; Kebudi R; Tüysüz B
    Ann Hum Genet; 2021 Sep; 85(5):155-165. PubMed ID: 33877690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification.
    Dastur RS; Kachwala MY; Khadilkar SV; Hegde MR; Gaitonde PS
    Neurol India; 2011; 59(6):803-9. PubMed ID: 22234189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1.
    Lee MJ; Su YN; You HL; Chiou SC; Lin LC; Yang CC; Lee WC; Hwu WL; Hsieh FJ; Stephenson DA; Yu CL
    Hum Mutat; 2006 Aug; 27(8):832. PubMed ID: 16835897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions.
    Steinmann K; Kluwe L; Cooper DN; Brems H; De Raedt T; Legius E; Mautner VF; Kehrer-Sawatzki H
    Eur J Hum Genet; 2008 May; 16(5):572-80. PubMed ID: 18212816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.
    Wu-Chou YH; Hung TC; Lin YT; Cheng HW; Lin JL; Lin CH; Yu CC; Chen KT; Yeh TH; Chen YR
    J Biomed Sci; 2018 Oct; 25(1):72. PubMed ID: 30290804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
    De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
    Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
    Ko JM; Sohn YB; Jeong SY; Kim HJ; Messiaen LM
    Pediatr Neurol; 2013 Jun; 48(6):447-53. PubMed ID: 23668869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.